S-55746

S-55746 · Institut de Recherches Internationales Servier

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for S-55746, covering 2024-07-25 to 2024-07-25. Get the full timeline:

Most recent: Clinical Trial Update: Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma [Phase 1]

See pricing